Articles by Editor

The move comes five months after it cut its dividend for the first time since World War Two. …read more […]

Spot gold fell 0.5% to $1,889.66 per ounce by 0357 GMT, after hitting a one-week high of $1,899.12 earlier in the session. Spot gold was on track to post it worst monthly fall since Nov. 2016, dropping 4% so far this month. U.S. gold futures were down 0.4% at $1,895.40. …read more […]

(Bloomberg) — U.S. equity-index futures turned lower as investors gauged whether either protagonist in the first American presidential debate emerged with the upper hand, and as traders recalibrated positions on the final day of this quarter. Crude oil retreated.S&P 500 futures were about 0.5% lower after the sparring between President Donald Trump and Democratic hopeful Joe Biden ended. Futures earlier rose as much as 0.7% during the debate, well within the range of swings that have prevailed recently during one of the U.S. stock market’s more volatile stretches. Treasuries were little changed.“What we’ve seen from the debate is the reinforcement …read more […]

(Bloomberg) — Alibaba Group Holding Ltd. foresees its cloud services arm turning profitable for the first time this year, a milestone for the decade-old business that underscores how Asia’s largest corporation expects a return to pre-pandemic levels as China’s economy rebounds.Alibaba’s shares rose as much as 4% in Hong Kong, their biggest intraday gain in over a month. Its internet computing business is growing roughly 60% at an annual revenue run rate of about $7 billion, Chief Financial Officer Maggie Wu told investors at an annual company conference. The unit should turn profitable in the year ending March, she said.Cainiao, …read more […]

Lonza is confident that U.S. and Swiss plants it is building to help make Moderna’s COVID-19 vaccine candidate will be ready for commercial production this year, executives at the Swiss company said on Tuesday. New production lines at Lonza’s site in Portsmouth, New Hampshire, aim to start making vaccine ingredients in November, while three lines in Visp, deep in a valley in the Swiss Alps – to supply 300 million vaccine doses annually – should begin delivering by December. There is no approved COVID-19 vaccine yet, but several are in advanced trials, including from Pfizer Inc, Johnson & …read more […]

“We hope these data will support an EUA” (emergency use authorization) from the U.S. Food and Drug Administration, Regeneron Chief Scientific Officer George Yancopoulos said on a conference call. The treatment, REGN-COV2, is also being studied for use in hospitalized patients, and for prevention of infection in people who have been exposed to COVID-19. Regeneron declined to comment on when those trial results are expected. …read more […]

The delayed award provides a fresh source of potential trade friction weeks before November’s U.S. presidential election, after Washington last year began imposing tariffs on $7.5 billion worth of EU goods over state support for Boeing rival Airbus. The two sides have been locked in a 16-year-old dispute at the Geneva-based WTO over aid to their aircraft industries in a pair of cases that together represent the world’s largest-ever corporate trade dispute. …read more […]

Stock futures drifted higher Tuesday evening as investors considered the first presidential debate and continued to eye developments among congressional lawmakers for further fiscal stimulus. …read more […]

The U.S. Treasury said on Tuesday it had closed loans to seven large airlines hit hard by the coronavirus pandemic and urged Congress to save tens of thousands of airline jobs by extending billions in payroll assistance. The Treasury said in a statement the seven carriers were Alaska Airlines, American Airlines, Frontier Airlines, JetBlue Airways Corp , Hawaiian Airlines, SkyWest Airlines and United Airlines. …read more […]

…read more […]

“Tim has brought unparalleled innovation and focus to his role as CEO and demonstrated what it means to lead with values and integrity,” Apple’s board of directors said in a statement. “For the first time in nearly a decade, we are awarding Tim a new stock grant that will vest over time in recognition of his outstanding leadership and with great optimism for Apple’s future as he carries these efforts forward.” Cook is in the ninth year of his 10-year grant from 2011. …read more […]

Muddy Waters Research is betting against Nano-X Imaging Ltd. (NASDAQ:NNOX), saying that the company has “important similarities” with Nikola. In a research report, the investment firm writes that NNOX has “no product to sell other than its stock.” NNOX is a medical imaging technology company that has ensured cost-reduced imaging system. Muddy Waters believes that the […] …read more […]

For whatever reason, everyone is always asking me about my office – and my trade setup. How many monitors do you have? What systems do you use? And so on… So today, I’ll take you where nobody has ever gone before… Inside my office. In the video below, you can see – in real time – exactly how I trade from my own command center. Check it out!

Our strategies make The War Room something unique and profitable.
We’ve handed members an insane 76.95% win rate since we launched!
Over that time frame, we’ve had a 10.04% average gain with an average holding …read more […]

If you are looking for another successful biotech story in 2020, then look away now. Shares of Amarin (AMRN) have been under the cosh this year, as the company has battled its way through the courts to no avail.Amarin lost a patent case, and then its appeal too, against generic drug makers Hikma Pharmaceuticals and Dr. Reddy’s, who have their own plans for versions of Amarin’s high triglyceride treatment Vascepa. Investors have jumped ship in the meantime, sending shares down by a mighty 80% year-to-date.But conversely, if you are looking to pick up some shares on the cheap, SBV Leerink …read more […]

Zoom Video Communications (Nasdaq: ZM) has been nothing short of a stock market sensation in 2020.
It entered the year at $68. Now it trades for more than $480.
That is what we call a “seven-bagger” in this business.

If you owned $10,000 worth of Zoom shares on January 1, those shares are now worth more than $70,000.
I most definitely wish I had owned shares of Zoom on January 1 and held through today…
But if I did, I can tell you the first thing I would do…
I would sell them. Immediately.
Zoom’s Spectacular Run
I don’t dislike Zoom’s business. Quite the contrary, actually.
Zoom produces what …read more […]